Posted by
Adjunctive Riluzole Shows Promise in Treatment-Resistant Depression

Adjunctive Riluzole Shows Promise in Treatment-Resistant Depression

The glutamate blocker riluzole may have longer-term beneficial effects as adjunctive treatment for some patients with treatment-resistant depression, according to results of a trial published in the Journal of Affective Disorders. The US Food and Drug Administration approved riluzole for the treatment of amyotrophic lateral sclerosis in 1994. It inhibits presynaptic release of glutamate and acts directly […]

Posted by
Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent use of sleep medications appears to be associated with increased long-term risk of dementia, particularly among older white adults, according to research presented at the Alzheimer’s Association International Conference in Los Angeles this week. “Based on our findings, we recommend that clinicians make more effort to be aware of their patients’ sleep problems including […]